Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers

Breast cancer (BC) remains a significant healthcare challenge. Routinely, the treatment strategy is determined by immunohistochemistry (IHC)-based assessment of the key proteins such as estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuncman, Wojciech, Orzechowska, Magdalena, Kuncman, Łukasz, Kordek, Radzisław, Taran, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595326/
https://www.ncbi.nlm.nih.gov/pubmed/34804912
http://dx.doi.org/10.3389/fonc.2021.660318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595326/
https://www.ncbi.nlm.nih.gov/pubmed/34804912
http://dx.doi.org/10.3389/fonc.2021.660318

Ejemplares similares